** Shares of primary care provider Cano Health fall 31% to $5.67
** Co reports Q3 loss of $91.87/shr vs analysts' average loss estimate of $18.41/shr
** Says the loss was driven by an impairment charge of $354 mln paired with higher third-party medical costs
** The company had a CEO change in August after it flagged its ability to continue as a going concern
** Including session moves, stock down 95.7% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。